161 related articles for article (PubMed ID: 11840345)
1. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha.
Cocuzzi ET; Bardenstein DS; Stavitsky A; Sundarraj N; Medof ME
Curr Eye Res; 2001 Aug; 23(2):86-92. PubMed ID: 11840345
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes [corrected].
Pasch MC; Bos JD; Daha MR; Asghar SS
Eur J Immunol; 1999 Jan; 29(1):100-8. PubMed ID: 9933091
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
4. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues.
Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line.
Bjørge L; Jensen TS; Matre R
Cancer Immunol Immunother; 1996 Mar; 42(3):185-92. PubMed ID: 8640847
[TBL] [Abstract][Full Text] [Related]
6. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
8. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.
Varsano S; Rashkovsky L; Shapiro H; Radnay J
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):522-9. PubMed ID: 9730881
[TBL] [Abstract][Full Text] [Related]
9. Release of complement regulatory proteins from ocular surface cells in infections.
Cocuzzi E; Guidubaldi J; Bardenstein DS; Chen R; Jacobs MR; Medof EM
Curr Eye Res; 2000 Nov; 21(5):856-66. PubMed ID: 11262607
[TBL] [Abstract][Full Text] [Related]
10. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
11. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
[TBL] [Abstract][Full Text] [Related]
12. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
[TBL] [Abstract][Full Text] [Related]
13. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
14. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
15. Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line.
Varsano S; Kaminsky M; Kaiser M; Rashkovsky L
Thorax; 2000 May; 55(5):364-9. PubMed ID: 10770816
[TBL] [Abstract][Full Text] [Related]
16. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
Mason JC; Lidington EA; Ahmad SR; Haskard DO
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C578-87. PubMed ID: 11832343
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
19. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland.
Bardenstein DS; Dietz Y; Lass JH; Medof ME
Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649
[TBL] [Abstract][Full Text] [Related]
20. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
